Synthesis and structure-activity relationships of naphthamides as dopamine D3 receptor ligands

被引:24
作者
Huang, YS
Luedtke, RR
Freeman, RA
Wu, L
Mach, RH [1 ]
机构
[1] Wake Forest Univ, Sch Med, Dept Radiol, PET Ctr, Winston Salem, NC 27157 USA
[2] Wake Forest Univ, Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA
[3] Univ N Texas, Ctr Hlth Sci, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA
关键词
D O I
10.1021/jm0100077
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of naphthamides were synthesized, and the affinities of these compounds were determined for dopamine D-2 and D-3 receptors using radioligand binding techniques. The naphthamide compounds that were prepared include N-(1-alkylpiperidin-4-yl)-4-bromo-1-methoxy-2-naphthamides (1-6), (S)-N-(1-alkylpyrrolidin-3-yl)-4-bromo-1-methoxy-2-naphthamides (7-12), (R)-N-(1-alkylpyrrolidin-3-yl)-4-bromo-1-methoxy-2-naphthamides (13-18), (S)-N-(1-alkyl-2-pyrrolidinylmethyl)-4-bromo-1-methoxy-2-naphthamides (19 -25), (R)-N-(1-alkyl-2-pyrrolidinylmethyl)-4-bromo-1-methoxy-2-naphthamides (26-31), and N-(9-alkyl-9-azabicyclo-[3.3.1]nonan-3 beta -yl)-4- bromo-1-methoxy-2-naphthamides (32, 33). The results of in vitro radioligand binding studies indicated that the majority of the naphthamide analogues bound with high affinity at both the D-2 and D-3 dopamine receptor subtypes and most of the compounds demonstrated some selectivity for the dopamine D-3 dopamine receptor subtype. These results demonstrated that both the structure of the central amine moiety (piperidine, pyrrolidine, and 9-azabicyclo[3.3.1]nonane) ring and the N-(alkyl) substitution on the amine significantly effects the binding affinity at D-2 and D-3 dopamine receptors. The bulkiness of the N-(1-alkyl) substituent was found to (a) have no effect on pharmacologic selectivity, (b) increase the affinity at Ds receptors, or (c) decrease the affinity at D-2 receptors. The most potent analogue in this series was (S)-N-(1-cycloheptylpyrrolidin-3-yl)-4-bromo-1-methoxy-2-naphthamide (10), which had equilibrium dissociation (K-i) values of 1.8 and 0.2 nM for D-2 and D-3 receptors, respectively. The most selective analogue was (R)-N-(1-cycloheptyl-2-pyrrolidinylmethyl)-4-bromo-1-methoxy-2-naphthamide (30), which had K-i values of 62.8 and 2.4 nM for D-2 and D-3 receptors, respectively. Radioligand binding results for sigma receptors indicated that the structure of the amine moiety and the N-(l-alkyl) substitutions also significantly influence the affinity and selectivity of these compounds at the sigma (1) and sigma (2) sigma receptor subtypes. The two naphthamides containing a 9-azabicyclo[3.3.1]nonan-3 beta -yl central ring were found to be selective for sigma (2) receptors.
引用
收藏
页码:1815 / 1826
页数:12
相关论文
共 43 条
[1]  
BOUNDY VA, 1993, J PHARMACOL EXP THER, V264, P1002
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]   D-3 receptor test in vitro predicts decreased cocaine self-administration in rats [J].
Caine, SB ;
Koob, GF ;
Parsons, LH ;
Everitt, BJ ;
Schwartz, JC ;
Sokoloff, P .
NEUROREPORT, 1997, 8 (9-10) :2373-2377
[4]   SULPIRIDE - AN ANTIPSYCHOTIC WITH SELECTIVE DOPAMINERGIC ANTAGONIST PROPERTIES [J].
CALEY, CF ;
WEBER, SS .
ANNALS OF PHARMACOTHERAPY, 1995, 29 (02) :152-160
[5]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[6]   ASSOCIATION BETWEEN SCHIZOPHRENIA AND HOMOZYGOSITY AT THE DOPAMINE-D3 RECEPTOR GENE [J].
CROCQ, MA ;
MANT, R ;
ASHERSON, P ;
WILLIAMS, J ;
HODE, Y ;
MAYEROVA, A ;
COLLIER, D ;
LANNFELT, L ;
SOKOLOFF, P ;
SCHWARTZ, JC ;
GILL, M ;
MACHER, JP ;
MCGUFFIN, P ;
OWEN, MJ .
JOURNAL OF MEDICAL GENETICS, 1992, 29 (12) :858-860
[7]   MECHANISMS OF ACTION OF ATYPICAL ANTIPSYCHOTIC-DRUGS - IMPLICATIONS FOR NOVEL THERAPEUTIC STRATEGIES FOR SCHIZOPHRENIA [J].
DEUTCH, AY ;
MOGHADDAM, B ;
INNIS, RB ;
KRYSTAL, JH ;
AGHAJANIAN, GK ;
BUNNEY, BS ;
CHARNEY, DS .
SCHIZOPHRENIA RESEARCH, 1991, 4 (02) :121-156
[8]  
GONZALEZALVEAR GM, 1994, J PHARMACOL EXP THER, V271, P212
[9]  
Hammond PS, 1999, MED CHEM RES, V9, P35
[10]   RAT-LIVER AND KIDNEY CONTAIN HIGH-DENSITIES OF SIGMA(1) AND SIGMA(2) RECEPTORS - CHARACTERIZATION BY LIGAND-BINDING AND PHOTOAFFINITY-LABELING [J].
HELLEWELL, SB ;
BRUCE, A ;
FEINSTEIN, G ;
ORRINGER, J ;
WILLIAMS, W ;
BOWEN, WD .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 268 (01) :9-18